Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2025-07-29
2025-07-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prosthesis
Patient is temporarily fit with Point Mini finger prosthetic system
Point Mini
The Point Mini finger prosthetic system consists of 1-4 ratcheting mechanical digits and mounting brackets
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Point Mini
The Point Mini finger prosthetic system consists of 1-4 ratcheting mechanical digits and mounting brackets
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intact thumb with full range of motion
* Fluent in English
* Between the ages of 5 and 15 years
Exclusion Criteria
* Unhealed wounds
* Significant cognitive deficits as determined upon clinical evaluation
* Significant neurological deficits as determined upon clinical evaluation
* Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
* Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation
* Serious uncontrolled medical problems as judged by the project therapist
5 Years
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Denver
OTHER
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Point Designs
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Levin Sliker, PhD
Role: PRINCIPAL_INVESTIGATOR
CEO, Point Designs
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado Denver | Anschutz Medical Campus
Aurora, Colorado, United States
Point Designs
Lafayette, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
445969
Identifier Type: -
Identifier Source: org_study_id